Pampusch Mary S, Haran Kumudhini Preethi, Hart Geoffrey T, Rakasz Eva G, Rendahl Aaron K, Berger Edward A, Connick Elizabeth, Skinner Pamela J
Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN 55108, USA.
Division of Infectious Disease and International Medicine, Department of Medicine, Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA.
Mol Ther Methods Clin Dev. 2019 Sep 30;16:1-10. doi: 10.1016/j.omtm.2019.09.007. eCollection 2020 Mar 13.
Chimeric antigen receptor (CAR)-T cells show great promise in treating cancers and viral infections. However, most protocols developed to expand T cells require relatively long periods of time in culture, potentially leading to progression toward populations of terminally differentiated effector memory cells. Here, we describe in detail a 9-day protocol for CAR gene transduction and expansion of primary rhesus macaque peripheral blood mononuclear cells (PBMCs). Cells produced and expanded with this method show high levels of viability, high levels of co-expression of two transduced genes, retention of the central memory phenotype, and sufficient quantity for immunotherapeutic infusion of 1-2 × 10 cells/kg in a 10 kg rhesus macaque. This 9-day protocol may be broadly used for CAR-T cell and other T cell immunotherapy approaches to decrease culture time and increase maintenance of central memory populations.
嵌合抗原受体(CAR)-T细胞在治疗癌症和病毒感染方面显示出巨大的前景。然而,大多数用于扩增T细胞的方案需要在培养中花费相对较长的时间,这可能导致向终末分化效应记忆细胞群体发展。在此,我们详细描述了一种用于原代恒河猴外周血单个核细胞(PBMC)的CAR基因转导和扩增的9天方案。用这种方法产生和扩增的细胞显示出高活力、两个转导基因的高共表达水平、中央记忆表型的保留,并且在一只10千克的恒河猴中产生的细胞数量足以进行1-2×10个细胞/千克的免疫治疗性输注。这个9天方案可广泛用于CAR-T细胞和其他T细胞免疫治疗方法,以减少培养时间并增加中央记忆群体的维持。